Clinical Trials Directory

Trials / Completed

CompletedNCT06604429

Quality of Life Variations Among Adolescent Females Following Virtual Reality Games Approach

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Mina Atef Georgui Elias · Academic / Other
Sex
Female
Age
12 Years – 17 Years
Healthy volunteers
Not accepted

Summary

to compare the effects of virtual reality games, aerobic exercise, and dietary modifications on Quality of Life among adolescent females.

Detailed description

The study will assess whether virtual reality games, aerobic exercise, and dietary modifications lead to significant differences in Quality of Life scores, and perceived exertion as measured by the Borg scale. Additionally, the study will evaluate whether these interventions produce varying impacts on psychological factors such as depression, anxiety, and stress, and on physical measurements like waist circumference (WC) and body fat composition.

Conditions

Interventions

TypeNameDescription
OTHERAerobic exerciseaerobic exercises in form of cycle ergometer training (Each girl started session with a 5 min of warm-up. The exercise phase is performed at 65-75% of age-predicted peak heart rate using an orbitrack device for 20 minutes). Finally, a 5 min cool-down period is permitted, the total session that would be applied about 30 min.
OTHERDiet AdviceAdolescent girls participated in the study receive diet advices based on a balanced low calorie diet (1500 Kcal)
OTHERVirtual reality exerciseVirtual reality game exercise involves 25 min of exercise where adolescent girl immersed in the game and did physical activities for the upper and lower extremities according to the game's requirements, and finally a 5 min cool-down part to lower the heart rate and end the session with static flexibility routines, the total session that would be applied about 30 min of Virtual reality exercises.

Timeline

Start date
2023-10-01
Primary completion
2024-09-30
Completion
2024-11-01
First posted
2024-09-19
Last updated
2024-12-05

Locations

3 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06604429. Inclusion in this directory is not an endorsement.